Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

3.31
Delayed Data
As of 3:59pm ET
 -0.12 / -3.50%
Today’s Change
2.58
Today|||52-Week Range
5.35
-6.50%
Year-to-Date
Will PDL BioPharma (PDLI) Continue to Surge Higher?
Sep 20 / Zacks.com - Paid Partner Content
4 Biotech Stocks to Buy as Election Fever Rises
Sep 13 / Zacks.com - Paid Partner Content
Forget Novavax, Buy These 4 Biotech Stocks Instead
Sep 16 / Zacks.com - Paid Partner Content
Biotech Stocks Bounce Back in Monday Trading: 3 Picks
Sep 13 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Mylan, ANI Pharmaceuticals, Cambrex, PDL BioPharma...
Sep 14 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close3.43
Today’s open3.43
Day’s range3.30 - 3.43
Volume57,426
Average volume (3 months)1,439,553
Market cap$567.8M
Dividend yield6.04%
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-74.67%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.01%
P/E ratio2.4
Price/Sales0.99
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc+0.06+0.62%
BLCMBellicum Pharmaceuti...-1.23-5.98%
ATRAAtara Biotherapeutic...-0.23-1.14%
MCRBSeres Therapeutics I...-0.39-2.91%
Data as of 3:59pm ET, 09/26/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

Search for Jobs